NAGASE

NAGASE is a Japan-based trading house founded in 1832, specialising in the supply of Active Pharmaceutical Ingredients (APIs), intermediates, and fine chemicals. With a strong focus on the pharmaceutical industry, NAGASE is dedicated to supporting the development of biologics, vaccines, and cell-based therapeutics. The company operates manufacturing units such as Nagase Viita Co., Ltd., which is recognised as the world's largest commercial manufacturer of saccharide-based excipients, offering high-purity and low-endotoxin ingredients.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Intermediates
- Fine Chemicals
- Raw materials for nucleotide production
- Support for large and commercial GMP oligonucleotide/Peptide APIs production

NAGASE continues to be a dependable supplier to the pharmaceutical industry, committed to delivering high-quality products and solutions. For more information, please visit nagase.co.jp.